Funding news
Shockwave Medical logo

Revolutionizing Cardiovascular Treatment: Shockwave Medical Secures $131 Million in Funding for Advanced Technology Development

Recently funded · $13.1BMedical Equipment Manufacturing

Get the full Shockwave Medical company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Shockwave Medical, a pioneering force in the treatment of advanced cardiovascular disease, recently announced a monumental funding achievement of $13.1 million. This significant investment underscores the growing confidence in Shockwave's innovative approach to addressing calcified plaque, a common complication in cardiovascular conditions that can lead to severe health risks. The company’s breakthrough Intravascular Lithotripsy (IVL) technology is inspired by three decades of success in kidney stone treatment, merging safety and efficacy into the realm of cardiovascular care. By utilizing sonic pressure waves, Shockwave's IVL catheters precisely target and disrupt hardened calcium deposits without damaging surrounding soft tissue. This targeted disruption allows for the gentle balloon dilatation of stenotic arteries, effectively restoring blood flow with minimized risk. The capital raised will be instrumental in expanding the reach of Shockwave Medical’s transformative technology and accelerating research and development efforts to enhance patient outcomes and revolutionize the interventional landscape. With this funding, Shockwave Medical is poised to advance its mission of providing cutting-edge treatment options that significantly improve the quality of life for patients with advanced cardiovascular disease. Shockwave encourages stakeholders and interested parties to stay connected and informed about their advances at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL, as they embark on this exciting new chapter in their journey to transform cardiovascular care.

Other recently funded companies

View all